Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis

Abstract

Pneumococcal conjugate vaccine was highly cost-effective up to $40 per dose. Introduction of pneumococcal vaccine in the Latin American and Caribbean region is projected to reduce childhood mortality and to be highly cost-effective across a range of possible costs.